The Institute for Clinical and Economic Review (ICER) released a report on Monday assessing the clinical effectiveness and ...

The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...

The current model for managing chronic obstructive pulmonary disease (COPD) generally considers inhalers from the same therapeutic class to be clinically equivalent.1 When a long-acting muscarinic ...

Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.' ...

Pulmonary Or Respiratory Drug Delivery Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 The Business Research ...

New Delhi: Cancer patients facing prohibitive treatment costs in India can hope for relief: the nation's top drugmakers have ...

Teva has launched new digital inhaler ... generic version of GlaxoSmithKline’s blockbuster inhaler Advair (fluticasone+salmeterol). The competition for the product approved in asthma and COPD ...

More than $1 billion of those sales are based in the US, where sales grew 23% in the last year, with a recently-launched authorised generic from ... its label covering COPD in 2009.

Viagra is also available in the generic form ... often also used to treat pulmonary hypertension. A 2013 review showed that combining ED treatments that contain these medications with nitrates ...

"Heart disease takes years to decades to develop, and the process starts in the younger years," one heart doctor told us.

Does gabapentinoid use increase the risk of severe exacerbation in patients with chronic obstructive pulmonary disease (COPD) ...